FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and is intended for the treatment of cancer, in particular solid tumours. Pharmaceutical combination is used containing a composition containing parvovirus and a composition containing bevacizumab, the parvovirus is H-1 (H-1PV). Cancer treatment kit is also disclosed containing a first container, a second container, and a package insert, the first container contains at least one dose of a pharmaceutical composition containing parvovirus H-1, the second container contains at least one dose of a pharmaceutical composition containing bevacizumab.
EFFECT: group of inventions provides an increase in the effectiveness of therapy, prevention of relapses.
12 cl, 4 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PARVOVIRUS PREPARATION FOR TREATING TUMOURS | 2016 |
|
RU2698717C2 |
| CEREBRAL CANCER TREATMENT WITH ONCOLYTIC ADENOVIRUS | 2014 |
|
RU2689553C2 |
| METHOD OF OPTIMIZING LARGE-SCALE PRODUCTION OF PARVOVIRUS H-1 IN SUBSTANTIALLY SERUM-FREE MEDIUM | 2017 |
|
RU2714111C1 |
| METAPNEUMOVIRUS OF BIRDS IN ONCOLYSIS | 2012 |
|
RU2571925C2 |
| THERAPEUTIC COMPOSITIONS AND METHODS OF USING FOR TREATING CANCER | 2016 |
|
RU2720984C2 |
| ONCOLYTIC ADENOVIRUS FOR TREATING CANCER, USING IT, AND PHARMACEUTICAL COMPOSITION CONTAINING IT | 2010 |
|
RU2536931C2 |
| COMBINATION OF ONCOLYTIC VIRUS WITH MODULATORS OF IMMUNOLOGICAL CONTROL POINTS | 2015 |
|
RU2705780C2 |
| ONCOLYTIC ADENOVIRUSES ENCODING BISPECIFIC ANTIBODIES, AS WELL AS METHODS AND APPLICATIONS ASSOCIATED THEREWITH | 2016 |
|
RU2725799C2 |
| ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS | 2009 |
|
RU2520823C2 |
| RECOVERING VIRUS RELATED TO CANINE PARVOVIRUS-2 FROM RACOON | 2010 |
|
RU2565538C2 |
